What IHP Group does

IHP Group (Institut Histo-Pathologique) is a French private medical pathology group operating as a SELAS and employing approximately 220 staff including 50–55 specialist pathologist physicians. Founded in 1998 with its Nantes platform, the group has grown to six technical platforms across five French regions (Pays de la Loire, Île-de-France, Grand Est, Nouvelle-Aquitaine, and Centre-Val de Loire), processing approximately 900,000 diagnostic cases annually with a 4.2-day average turnaround. Core services include anatomo-cytopathology diagnostics, molecular pathology with NGS sequencing, and AI-assisted cancer screening, with the company having been the first European site to deploy Hologic's Genius AI cervical cancer screening system.

The company's underlying technology stack combines whole-slide digital pathology, proprietary AI diagnostic algorithms co-developed with DiaDeep (covering HER2, RO/RP, Ki-67 quantification in breast cancer, melanoma survival prediction, and HPV cell detection), and an NGS molecular pathology platform supporting targeted-therapy selection. IHP Data Hub provides access to over 3 million biological samples and associated clinical data for research and AI training. The group holds COFRAC ISO 15189 accreditation and is a member of INCa expert networks (CARADERM, Lymphopath, GFELC), with AFAQAP awarding the best national score (18/20) on PD-L1 immunohistochemistry quality testing in 2024.

IHP Group's business model is a B2B professional services structure in which it provides diagnostic services to French hospitals, clinics, and referring physicians (oncologists, gynecologists, surgeons, urologists), with revenue generated per case and reimbursed through the French national healthcare system and complementary insurance. Go-to-market is direct enterprise relationships with healthcare institutions across regions, supplemented by expert-network participation and medical conference engagement. The company has executed a roll-up strategy of regional pathology practices, completing mergers with Centre de Pathologie Atlantique (La Rochelle, 2023) and Cabinet de Pathologie Hippocrate (Reims, 2024) to extend geographic reach.

Name

IHP Group

Legal name

IHP Group

Website

https://ihp-group.fr

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Short description

IHP Group is a French private medical pathology group operating six technical platforms across five regions, employing 50+ specialist pathologists and processing approximately 900,000 cancer diagnostic cases annually. It serves French hospitals, clinics, and referring physicians with digital pathology, AI-assisted diagnostics, and NGS molecular testing.

Ownership category

akta.pro rank

Product category

Pathology Diagnostics Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Offices of Physicians (62111)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

akta.pro secondary industries

Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)

Keywords

• Cancer diagnostics
• Pathology services
• Molecular pathology
• Digital pathology
• Anatomical pathology

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Diagnostic Pathology Services: Anatomical and cytopathology diagnostic services billed to healthcare system, hospitals, clinics, and referring physicians. Services include screening, diagnosis, and molecular pathology testing for cancer detection and treatment guidance.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

IHP Group is a French medical pathology group that provides cancer screening, diagnosis, and molecular pathology services through 6 regional technical platforms. Its core service is anatomo-cytopathology analysis of tissue, biopsy, and cytology samples referred by hospitals, clinics, and physicians, supplemented by an NGS molecular pathology platform, AI-assisted digital pathology, and a Hologic Genius cervical cancer screening system. The group processes approximately 900,000 diagnostic cases per year with an average 4.2-day turnaround, supported by 50 specialist pathologist physicians and COFRAC ISO 15189 accreditation.

Product overview

IHP Group operates as a network of six technical pathology platforms providing anatomo-cytopathology diagnostic services across five regions in France. The core offering consists of cancer screening and diagnostic services, supplemented by a molecular pathology platform with NGS sequencing capabilities, digital pathology with AI-assisted diagnosis, and a biological sample banking service for research. Key modules include the Hologic Genius AI system for cervical cancer screening and deep learning algorithms developed with partner DiaDeep for breast cancer and melanoma analysis.

Differentiator

Problem solved

Functional benefit

Products and services

• Anatomo-Cytopathology Diagnostics Core diagnostic service providing analysis of tissue samples, cytology, biopsies, and surgical specimens for cancer detection and diagnosis. Delivered by 50 specialist pathologist physicians across 6 technical platforms in France, serving hospitals, clinics, and referring physicians with an average 4.2-day turnaround.
• Molecular Pathology Platform (NGS) High-throughput Next Generation Sequencing (NGS) molecular pathology platform enabling comprehensive molecular genetics analysis of cancers. Provides results for targeted therapy access, diagnostic orientation, therapeutic strategy, and patient follow-up. Used by oncologists and referring physicians to guide precision therapy decisions.
• Genius Cervical Cancer Screening System AI-powered cervical cancer screening system (Hologic Genius) deployed by IHP Group, the first European site to adopt it. Uses digital cytology with AI preselection of cells of interest, improving smear analysis efficiency and diagnostic quality.
• IHP Data Hub - Biological Sample Banking Biological sample bank containing over 3 million human biological samples, partnered with IHP Data Hub to support research projects with personalized tissue banks and associated pseudonymized clinical data, including data for AI algorithm training.

Quantifiable outcome

• 900,000 annual diagnostic cases processed
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• DiaDeepcoreTechnology or Integration · 1 January 2022Strategic partnership for co-development of AI diagnostic algorithms for pathology. Collaboration includes development of deep neural networks for quantification of RO, RP, and Ki-67 in breast cancer; HER2 quantification; and other AI applications for improving diagnostic accuracy and efficiency.
• HologiccoreTechnology or IntegrationFirst European site to deploy Hologic Genius AI system for cervical cancer screening. The system uses digital cytology with AI preselection of cells of interest, improving analysis time and diagnostic comfort while maintaining quality.
• IHP Data HubcoreStrategic or Co-development PartnerData partnership for research support, providing access to over 3 million biological samples and associated clinical data for research projects and AI algorithm training while ensuring data privacy through pseudonymization and anonymization.
• AstraZenecaminorGTM or Marketing PartnerCollaboration for prostate cancer awareness evening bringing together urologists, oncologists, and pathologists to discuss latest recommendations and targeted therapies.
• Institut Français du SeinminorStrategic or Co-development PartnerCollaboration for patient education and awareness on breast cancer, including debate evenings combining medical expertise with patient support.
• Ouest Pathologie France, Cypath, Medipath FranceminorChannel Partner/ Reseller/ DistributorProfessional pathology network collaborations for cytogenomics and molecular pathology expertise sharing at GFCO conferences.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Cerba HealthCare: Cerba is a major French-headquartered specialty/medical laboratory group offering advanced diagnostics including anatomic pathology and molecular testing. It is comparable to IHP as a French specialty lab operator serving hospitals and referring physicians with a similar B2B healthcare services model.
• Inovie: Inovie is one of the largest French private medical biology and pathology groups, operating a network of laboratories across France. It is the most direct structural competitor to IHP in French anatomic pathology, pursuing a similar multi-site, M&A-driven regional consolidation model.
• Cypath: Cypath is a French private pathology group operating in the Lyon region and named in IHP's data as a professional network collaborator. It is a direct peer in French private anatomic pathology with a similar specialist-driven, multi-site operating model.
• Medipath: Medipath is a French private pathology group operating multiple sites in southern France, and is explicitly named in IHP's data as a network collaborator. It is a direct structural peer in French private anatomic pathology with a comparable multi-site specialist model.

Emerging players

• Paige: Paige is a US-based AI digital pathology company developing FDA-cleared AI algorithms for cancer diagnosis. It is comparable to IHP's AI-assisted diagnostic capability (co-developed with DiaDeep), representing a potential technology partner or competitor as AI pathology becomes mainstream.

Regional players

• Ouest Pathologie France: Ouest Pathologie France is a French regional pathology group explicitly named in IHP's data as a collaborator in cytogenomics and molecular pathology. It is a regional peer operating in adjacent French territory with comparable anatomic pathology services.

Broad incumbents

• Eurofins Genoma: Eurofins Genoma is the clinical diagnostics arm of Eurofins, offering genetic and molecular pathology testing across Europe. It is comparable to IHP's molecular pathology/NGS service line, with a much broader international footprint and testing menu.
• Synlab: Synlab is Europe's largest medical diagnostics services provider, operating clinical labs including pathology across multiple countries. Comparable to IHP as a pathology services provider but at significantly greater scale, geographic breadth, and with PE backing (Cinven).
• Unilabs: Unilabs is a major European diagnostics group offering clinical laboratory and pathology services across multiple geographies. Comparable to IHP in core anatomic pathology services, with substantially larger scale and A.P. Møller Holding ownership.

Others

• Hologic: Hologic is a US medical technology company whose Genius AI cervical cancer screening system is deployed at IHP as a core technology partner. Hologic is comparable to IHP as a technology enabler in the cervical cancer screening workflow, though not a direct pathology services competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ihp-group

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IHP Group